Revisiting propafenone toxicity.
BMJ Case Rep
; 20172017 Apr 26.
Article
em En
| MEDLINE
| ID: mdl-28446489
ABSTRACT
Propafenone is a Vaughan Williams class 1c antiarrhythmic medication widely used for treatment of arrhythmias. Although the long-term safety of propafenone use has not been established, it is commonly used for treatment of atrial fibrillation in patients with no structural heart disease. Propafenone is well known as pill-in-the-pocket treatment for its effect in terminating paroxysmal episodes of atrial fibrillation. Herein, we discuss an unusual adverse reaction to propafenone in a patient who presented with symptomatic bradycardia and hypotension. The aim of this article is to increase physician awareness for propafenone toxicity and its management, with a focused literature review on propafenone pharmacotherapy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Propafenona
/
Bradicardia
/
Hipotensão
/
Antiarrítmicos
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article